Physician profile
Robert Dirksen
NPI 1174669899
$1,332.16
in general payments reported to CMS, 2019-2025
17 companies · $444 in 2025
The $444 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $40.67 · 2022: $286 · 2023: $183 · 2024: $208 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $835.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $336.35 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Glaukos Corporation | $159.48 | 2025 | Kxl System (Not Refurbished) |
| Sight Sciences, INC. | $125.42 | 2022 | |
| Sun Pharmaceutical Industries INC. | $110.20 | 2023-2025 | Cequa |
| Heru, INC. | $110.16 | 2022 | |
| Shire North American Group INC | $108.54 | 2019 | |
| Oyster Point Pharma, INC. | $76.37 | 2023-2025 | Tyrvaya, Ryzumvi |
| Biotissue Holdings INC. | $50.36 | 2022 | |
| Novartis Pharmaceuticals Corporation | $43.76 | 2019 | |
| Optos, INC. | $40.67 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $39.56 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $34.83 | 2025 | Xdemvy |
| Dompe US, INC. | $25.26 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $19.83 | 2023 | Lipiflow System Activator (Disposable) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.13 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.84 | 2025 | Tepezza |
| Astellas Pharma US INC | $15.40 | 2024 | Izervay |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dirksen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.